Navigating Cardiotoxicity in Modern Cancer Therapy - Ep 181
About this episode
The episode discusses the expanding concerns of cardiotoxicity in cancer therapy with a focus on types, monitoring, and management.
In this episode, Pharmacotherapy scientific editor Jim Koeller interviews hematology-oncology specialist Dennis Marjoncu about Dr. Marjoncu's narrative review article “ Cancer Therapy-Induced Cardiotoxicity ”. They discuss how cardiotoxicity concerns have expanded beyond anthracyclines. They review cardiotoxicity types, monitoring approaches, management principles, drug-interaction considerations, limited prevention data, guideline gaps, and the need for better risk stratification and trial-based cardiac data.
More episodes of ACCP JOURNALS
- High-Value Interventions Primary Care Practices Might Be Overlooking: Clinical Pharmacy Services – Ep 180
- Enhancing Pharmacotherapy Through Artificial Intelligence: From Prediction Models to Practice – Ep 179
- A Medical Writing Rotation: Flipping the Odds on Resident Scholarship - Ep 178
- Thinking Like Tree Farmers Not Muffin Makers: Why We Need a Competency-based Framework at all Levels of Professional Education - Ep 177
- An Aging HIV+ Population: The Urgent Need (and Opportunities) for HIV-trained Pharmacists - Ep 176
- Terlipressin Administration Strategies in Hepatorenal Syndrome–Acute Kidney Injury - Ep 175
Explore listener stats, chart rankings, contacts and more on the ACCP JOURNALS podcast page.